Transasia Bio-Medicals’ international hematology range is now in Chandigarh

Among India’s top 5 cities in per capita income, Chandigarh is a natural market for European technology; priced 25% below comparable options, new range to make world-class diagnostics affordable for masses

0
660

Transasia Bio-Medicals’ international hematology range is now in Chandigarh: Transasia Bio-Medicals Ltd., India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global players focused on emerging markets.

Transasia Bio-Medicals’ international hematology range is now in ChandigarhBacked by European R&D, the 3-Part Differential Analyzer(3PDA) to 5-Part DifferentialAnalyzer (5PDA) fully automated haematology analyzers, reagents and controls include a number of features to help institutions, clinicians and lab technologists offer accurate diagnosis. Manufactured by ErbaLachema (100% owned subsidiary of Transasia) in Europe, the H 360, H 560 and ELite 580 hematologyanalyzers are widely used in the European and global market.

Hematologyanalyzers are extensively used in patient and research settings to count and characterize blood cells for disease detection and monitoring. Basic analyzers return a complete blood count (CBC) with a three-part differential white blood cell (WBC) count. Sophisticated analyzers measure cell morphology and can detect small cell populations to diagnose rare blood conditions.

In addition to the routine parameters, the new hematology range offers additional parameters such as Platelet Large Cell Ratio (PLCR) and Platelet Large Cell Concentration (PLCC) that are reported by advanced automated haematology analyzers to add more insight to the possible causes of abnormal platelet counts.The instruments thus become particularly relevant for Chandigarh, since there is a huge influx of rural masses from Himachal Pradesh and Punjab. It has been observed that a majority of these patients suffer from anemia, thalassemia and other hemoglobinopathies.

Also Read :   Pumpkart.com Launches First O2O Hybrid Store in Chandigarh

Addressing the media, Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals Ltd., said, “We are glad to be introducing our hematology range, here today. Chandigarh has established itself as one of the top places in India offering quality healthcare services.The Post Graduate Institute of Medical Education and Research (PGIMER), with its strong academic faculty, is one of the most premium medical institutes of India. Apart from this, in the last 5 years alone, Punjab Health Systems Corporation (PHSC), has done an excellent job of ensuring the availability of routine blood tests in all districts and rural areas by providing the latest biochemistry, hematology and ELISA analyzers in diagnostic centres. Also, the Government Multi Specialty Hospital, the oldest in the city, caters to a huge patient base.Transasia shares a long-standing association with both these institutes, with a majority of our instruments of different specialties installed at these places. Having among the highest per capita income, people of Chandigarh, are willing to spend on technology and automation for better healthcare facilities. Thus making it the most relevant market for Transasia to introduce its European technology.”

“As per industry reports in 2018, India’s medical devices industry is pegged at a $5.2 billion (Rs. 35,097.40 crore), most of which is imported. It is players like Transasia who are at the forefront of changing it and driving Make in India,” he further added.

Also Read :   Sunday 1st Weekend Dilwale Movie 3rd Day Box Office Collection Report

India ranks 145th among 176 countries on the quality and accessibility of healthcare parameter. Limited access to quality medical infrastructure, including skilled manpower and technologies have been the pain points of over 70% of Indians who live in smaller towns and rural areas. Transasia has been focusing on indigenous development & technology adoption which facilitates affordable diagnostics through domestic manufacturing.

Talking about the newly launched range, Dr.Preet Kaur, M.D. Pathology, Business Unit Head, Transasia,said, “Accepted world-over for their quality, precision and ease-of-operation, the Erba range of hematology products will increase the adoption of automated hematology testing among Indian diagnostic labs.The range provides holistic solutions for clinical testing in general and targeted diagnostics which is an added advantage for pediatric and geriatric population. Other unique features include flagging of abnormal samples, RFID, large colored LCD touch screen, customizable reporting formats, ability to connect to a Laboratory Information System (LIS) for result output and ready-to-use reagents that are cyanide free and environment-friendly. By addressing many challenges that labs and pathologists face, Transasia is helping healthcare professionals (HCPs) focus on giving patients the best possible care.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here